rs2304051
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_003118.4(SPARC):c.120+42T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.094 in 1,591,912 control chromosomes in the GnomAD database, including 11,954 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.17 ( 4098 hom., cov: 32)
Exomes 𝑓: 0.086 ( 7856 hom. )
Consequence
SPARC
NM_003118.4 intron
NM_003118.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.57
Genes affected
SPARC (HGNC:11219): (secreted protein acidic and cysteine rich) This gene encodes a cysteine-rich acidic matrix-associated protein. The encoded protein is required for the collagen in bone to become calcified but is also involved in extracellular matrix synthesis and promotion of changes to cell shape. The gene product has been associated with tumor suppression but has also been correlated with metastasis based on changes to cell shape which can promote tumor cell invasion. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2015]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 5-151674570-A-G is Benign according to our data. Variant chr5-151674570-A-G is described in ClinVar as [Benign]. Clinvar id is 1296627.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.415 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SPARC | NM_003118.4 | c.120+42T>C | intron_variant | Intron 3 of 9 | ENST00000231061.9 | NP_003109.1 | ||
SPARC | NM_001309444.2 | c.120+42T>C | intron_variant | Intron 3 of 9 | NP_001296373.1 | |||
SPARC | NM_001309443.2 | c.117+42T>C | intron_variant | Intron 3 of 9 | NP_001296372.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.172 AC: 26176AN: 151964Hom.: 4077 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
26176
AN:
151964
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.101 AC: 25236AN: 249652 AF XY: 0.0981 show subpopulations
GnomAD2 exomes
AF:
AC:
25236
AN:
249652
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0857 AC: 123408AN: 1439830Hom.: 7856 Cov.: 26 AF XY: 0.0868 AC XY: 62319AN XY: 717820 show subpopulations
GnomAD4 exome
AF:
AC:
123408
AN:
1439830
Hom.:
Cov.:
26
AF XY:
AC XY:
62319
AN XY:
717820
Gnomad4 AFR exome
AF:
AC:
14375
AN:
32816
Gnomad4 AMR exome
AF:
AC:
2506
AN:
44422
Gnomad4 ASJ exome
AF:
AC:
2047
AN:
25898
Gnomad4 EAS exome
AF:
AC:
2943
AN:
39600
Gnomad4 SAS exome
AF:
AC:
11781
AN:
85630
Gnomad4 FIN exome
AF:
AC:
4255
AN:
53338
Gnomad4 NFE exome
AF:
AC:
79005
AN:
1092728
Gnomad4 Remaining exome
AF:
AC:
5892
AN:
59680
Heterozygous variant carriers
0
4776
9553
14329
19106
23882
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
3180
6360
9540
12720
15900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.173 AC: 26238AN: 152082Hom.: 4098 Cov.: 32 AF XY: 0.171 AC XY: 12703AN XY: 74356 show subpopulations
GnomAD4 genome
AF:
AC:
26238
AN:
152082
Hom.:
Cov.:
32
AF XY:
AC XY:
12703
AN XY:
74356
Gnomad4 AFR
AF:
AC:
0.420418
AN:
0.420418
Gnomad4 AMR
AF:
AC:
0.0886854
AN:
0.0886854
Gnomad4 ASJ
AF:
AC:
0.0893372
AN:
0.0893372
Gnomad4 EAS
AF:
AC:
0.0650077
AN:
0.0650077
Gnomad4 SAS
AF:
AC:
0.138704
AN:
0.138704
Gnomad4 FIN
AF:
AC:
0.0877077
AN:
0.0877077
Gnomad4 NFE
AF:
AC:
0.071313
AN:
0.071313
Gnomad4 OTH
AF:
AC:
0.153409
AN:
0.153409
Heterozygous variant carriers
0
895
1790
2685
3580
4475
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
258
516
774
1032
1290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
400
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Osteogenesis imperfecta type 17 Benign:1
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
Aug 20, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at